UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 31, 2007

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware

 

000-30941

 

34-1818596

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts

 

01915

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:   (978) 787-4000

 

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 




 

Item 2.02   Results of Operations and Financial Condition

On January 31, 2007, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for the quarter ended December 31, 2006. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

The information under this Item in this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01  Financial Statements and Exhibits

(c) Exhibits

Exhibit No.

 

Description

99.1

 

Press Release dated January 31, 2007

 

2




 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 31, 2007

 

 

Axcelis Technologies, Inc.

 

 

 

By:

 

/s/ STEPHEN G. BASSETT

 

 

 

 

Stephen G. Bassett
Executive Vice President
and Chief Financial Officer

 

3




 

Exhibit No.

 

Exhibit Index

99.1

 

Press Release dated January 31, 2007.

 

4



Exhibit 99.1

 

Company Contact:

 

Investor Contact:

 

Agency Contact:

Maureen Hart

 

Stephen Bassett

 

Heather Smith

Axcelis Technologies, Inc.

 

Axcelis Technologies, Inc.

 

Loomis Group

Tel: +1 (978) 787 4266

 

Tel: +1 (978) 787 4000

 

Tel: +1 (617) 638 0022

Fax: +1 (978) 787 4275

 

Fax: +1 (978) 787 9133

 

Fax: +1 (617) 638 0033

maureen.hart@axcelis.com

 

investor.relations@axcelis.com

 

smithh@loomisgroup.com

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR
 FOURTH QUARTER AND FULL YEAR 2006

Company reports strong results across the board and significant increase in system orders

BEVERLY, Mass. — January 31, 2007 — Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2006. The Company reported revenues of $123.3 million, compared to $122.8 million for the third quarter of 2006. Net income for the fourth quarter was $15.6 million, or $0.15 per share, compared to net income for the third quarter of 2006 of $12.5 million, or $0.12 per share. In the corresponding quarter for the previous year, the Company reported revenues of $92.9 million, and net loss of $1.3 million, or $0.01 per share, which included restructuring and related costs of $1.7 million, or $0.02 per diluted share.

For the full year 2006, the Company reported revenues of $461.7 million compared with $372.5 million in 2005. Net income for the year was $40.8 million, or $0.40 per share. In 2005, the Company reported a net loss of $3.9 million, or $0.04 per share, which included relocation and restructuring charges of $11.4 million, or $0.11 per share.

Commenting on the Company’s performance, Chairman and CEO Mary Puma said, “Axcelis delivered strong results across the board, and achieved a 66% quarter over quarter increase in system orders. Our operating results for 2006 exceeded our expectations, reflecting the strength of our core businesses and our early penetrations with our new Optima platform. Our actions in 2006 have laid the cornerstones for continued growth, which will include compelling market share gains from the Optima HD high current product line.”

Fourth Quarter Detail

Shipments and Margins

Shipments before provision for deferred revenue for the fourth quarter totaled $103.8 million. This compares to $128.1 million in the third quarter of 2006.

Geographically, Axcelis’ systems shipments were to:  Asia, 36%; North America, 38%; and Europe, 26%.




 

The ion implantation business accounted for 63% of total shipments in the fourth quarter while other products (dry strip, curing and RTP) accounted for 37%.

Service revenue (service labor, spare parts and consumables) was $43.2 million for the quarter, compared to $42.1 million in the third quarter of 2006.

Gross margin for the fourth quarter was 41.6%, compared to 43.4% in the preceding quarter.

Orders and Backlog

Orders (new systems bookings and service) received for the fourth quarter totaled $140.9 million, compared to $101.1 million for the third quarter of 2006. New systems bookings, excluding service, amounted to $97.7 million compared to $59 million for the preceding quarter.

Backlog plus deferred systems revenue at quarter end was $124.8 million. Backlog consists of systems only (i.e., excluding service contracts) that are generally scheduled to ship within six months.

Balance Sheet

Cash, cash equivalents and marketable securities increased by $22.0 million to $215.8 million at December 31, 2006. The Company ended the quarter with working capital of $284.9 million.

SEN Corporation, an SHI and Axcelis Company (“SEN”)

Axcelis owns 50% of SEN, a Japanese company that is licensed to make and sell certain Axcelis ion implanters in Japan. SEN’s operating results for the quarters ended December 31, 2006, and September 30, 2006, are as follows (in millions):

 

 

Three Months Ended
December 31, 2006

 

Three Months Ended
September 30, 2006

 

SEN Revenue

 

$

93.3

 

$

45.3

 

SEN System Shipments

 

73.7

 

62.6

 

SEN System Orders

 

59.7

 

48.1

 

Royalties Due Axcelis

 

2.5

 

2.2

 

Axcelis’ Share of SEN Net Income

 

8.5

 

2.4

 

 

Business Outlook

Stephen Bassett, Axcelis executive vice president and CFO, commented, “Our anticipated ramp of Optima implanter shipments will drive revenue growth in the latter half of  2007, resulting in an overall increase in revenues for the year.  Given timing of revenue recognition, our first quarter 2007 forecast does not reflect this upward trend.”

Axcelis’ financial outlook for the first quarter of 2007 includes revenues in the range of $90.0 million to $100.0 million. Gross margins in the first quarter are expected to be in the range of 42% to 43%. The Company forecasts first quarter earnings per share in the range of $0.02 to $0.06 per share.




 

Axcelis assumes no responsibility to update guidance. Axcelis will only confirm or update guidance via a press release.

Fourth Quarter 2006 Conference Call

The Company will be hosting a conference call today, Wednesday, January 31, 2007, beginning at 5:00 pm ET.  The purpose of the call is to discuss fourth quarter and full year 2006 results and to provide guidance for the first quarter of 2007.

The call will be available to interested listeners via an audio webcast that can be accessed through Axcelis’ home page at www.axcelis.com, or by dialing 1-800-479-1628 (1-719-457-2729 outside North America).  Participants calling into the conference call will be requested to provide the company name: Axcelis Technologies, the conference leader: Maureen Hart, and pass code: #4728559. A webcast replay will be available from 8:00 pm ET on January 31, 2007 until 5:00 pm ET March 2, 2007.

Safe Harbor Statement

This document contains forward-looking statements under the SEC safe harbor provisions.  These statements, which include our guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, our ability to implement successfully our profit plans, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

About Axcelis Technologies, Inc.

Axcelis Technologies, Inc., headquartered in Beverly, Massachusetts, provides innovative, high-productivity solutions for the semiconductor industry. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation, rapid thermal processing, and cleaning and curing systems. Axcelis also licenses its 50% owned joint venture, SEN Corporation, an SHI and Axcelis Company, to manufacture and sell certain implant products in Japan. The company’s Internet address is: www.axcelis.com.




Axcelis Technologies, Inc.
Consolidated Statements of Operations
In thousands, except per share amounts
(Unaudited)

 

 

Three months ended
December 31,

 

Twelve months ended
December 31,

 

 

 

2006

 

2005

 

2006

 

2005

 

Revenue

 

 

 

 

 

 

 

 

 

Systems

 

$

77,627

 

$

50,364

 

$

276,311

 

$

206,087

 

Services

 

43,193

 

40,920

 

176,199

 

157,644

 

Royalties, primarily from SEN

 

2,519

 

1,660

 

9,207

 

8,809

 

 

 

123,339

 

92,944

 

461,717

 

372,540

 

Cost of Revenue

 

72,075

 

54,953

 

270,203

 

218,109

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

51,264

 

37,991

 

191,514

 

154,431

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research & development

 

18,384

 

19,743

 

72,384

 

70,908

 

Sales and marketing

 

11,617

 

10,261

 

45,536

 

44,826

 

General and administrative

 

12,362

 

10,635

 

46,620

 

45,631

 

Amortization of intangible assets

 

656

 

612

 

2,551

 

2,448

 

Restructuring charges

 

535

 

1,070

 

682

 

6,497

 

 

 

43,554

 

42,321

 

167,773

 

170,310

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

7,710

 

(4,330

)

23,741

 

(15,879

)

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Equity income of SEN

 

8,532

 

4,391

 

19,266

 

15,751

 

Interest income

 

2,567

 

1,660

 

8,383

 

5,459

 

Interest expense

 

(2,428

)

(1,663

)

(9,085

)

(6,634

)

Other-net

 

(359

)

(677

)

478

 

(679

)

 

 

8,312

 

3,711

 

19,042

 

13,897

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

16,022

 

(619

)

42,783

 

(1,982

)

 

 

 

 

 

 

 

 

 

 

Income taxes

 

461

 

716

 

2,013

 

1,873

 

Net income (loss)

 

$

15,561

 

$

(1,335

)

$

40,770

 

$

(3,855

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share

 

 

 

 

 

 

 

 

 

Basic

 

$

0.15

 

$

(0.01

)

$

0.40

 

$

(0.04

)

Diluted

 

$

0.15

 

$

(0.01

)

$

0.40

 

$

(0.04

)

Shares used in computing net income (loss) per share

 

 

 

 

 

 

 

 

 

Basic

 

101,221

 

100,435

 

101,058

 

100,301

 

Diluted

 

101,874

 

100,435

 

101,361

 

100,301

 

 




Axcelis Technologies, Inc.
Consolidated Balance Sheets
In thousands
(Unaudited)

 

 

December 31,

 

December 31,

 

 

 

2006

 

2005

 

Assets

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

140,451

 

$

71,417

 

Marketable securities

 

63,200

 

93,797

 

Restricted cash

 

11,019

 

8,037

 

Accounts receivable, net

 

73,635

 

79,379

 

Inventories, net

 

160,107

 

109,972

 

Prepaid expenses and other current assets

 

26,639

 

32,767

 

Total current assets

 

475,051

 

395,369

 

Property, plant & equipment, net

 

66,678

 

71,443

 

Investment in SEN

 

126,688

 

108,815

 

Goodwill

 

46,773

 

46,773

 

Intangible assets

 

13,549

 

16,100

 

Restricted cash, long-term portion

 

1,137

 

3,195

 

Other assets

 

24,117

 

19,748

 

 

 

$

753,993

 

$

661,443

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

 

$

37,312

 

$

25,556

 

Accrued compensation

 

26,996

 

18,437

 

Warranty

 

5,229

 

5,739

 

Income taxes

 

3,906

 

3,021

 

Deferred revenue

 

28,811

 

30,140

 

Other current liabilities

 

13,670

 

11,333

 

Current portion, long term debt

 

74,217

 

 

Total current liabilities

 

190,141

 

94,226

 

Long-term debt

 

76,887

 

125,000

 

Long-term deferred revenue

 

5,054

 

11,177

 

Other long-term liabilities

 

4,349

 

4,999

 

Commitments and contingencies

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred stock

 

 

 

Common stock

 

101

 

101

 

Additional paid-in capital

 

469,967

 

466,454

 

Deferred compensation

 

 

(5,385

)

Treasury stock

 

(1,218

)

(1,218

)

Retained earnings (deficit)

 

9,583

 

(31,187

)

Accumulated other comprehensive loss

 

(871

)

(2,724

)

 

 

477,562

 

426,041

 

 

 

$

753,993

 

$

661,443